GEFITIN®
Product characteristics
Active substance: Gefitinib
Therapeutic group: Antineoplastic and immunomodulatory drugs. Antineoplastic drugs. Protein kinase inhibitors. Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors. Gefitinib. ATC code L01ХЕ02
Form: 10 tablets are placed in a blister pack made of aluminum and printed aluminum foil. 3 blister packs together with instructions for medical use in Kazakh and Russian are placed in a cardboard pack with a hologram of the manufacturer.
Package Type: Film-coated tablets, 250 mg
Download instruction